| __timestamp | Dr. Reddy's Laboratories Limited | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 4167274 |
| Thursday, January 1, 2015 | 62786000000 | 5247851 |
| Friday, January 1, 2016 | 62427000000 | 4925118 |
| Sunday, January 1, 2017 | 62453000000 | 14930297 |
| Monday, January 1, 2018 | 65724000000 | 25371768 |
| Tuesday, January 1, 2019 | 70421000000 | 23921274 |
| Wednesday, January 1, 2020 | 80591000000 | 25338236 |
| Friday, January 1, 2021 | 86645000000 | 20182966 |
| Saturday, January 1, 2022 | 100551000000 | 17562000 |
| Sunday, January 1, 2023 | 42907000000 | 25212000 |
| Monday, January 1, 2024 | 115557000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding the cost of revenue is crucial for assessing a company's financial health. Dr. Reddy's Laboratories Limited, a major player in the global market, has shown a remarkable 105% increase in its cost of revenue from 2014 to 2024. This growth reflects its expanding operations and market reach. In contrast, Pharming Group N.V., a smaller entity, has experienced a more modest increase of around 500% over the same period, indicating its strategic efforts to scale operations.
The data reveals the dynamic nature of the pharmaceutical industry, where strategic investments and market expansion play pivotal roles in shaping financial outcomes.
Cost of Revenue: Key Insights for Novo Nordisk A/S and Dr. Reddy's Laboratories Limited
Cost of Revenue Comparison: Johnson & Johnson vs Dr. Reddy's Laboratories Limited
Cost of Revenue: Key Insights for Sanofi and Pharming Group N.V.
Comparing Cost of Revenue Efficiency: GSK plc vs Dr. Reddy's Laboratories Limited
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
Biogen Inc. vs Dr. Reddy's Laboratories Limited: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Biogen Inc. and Pharming Group N.V.
Neurocrine Biosciences, Inc. vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Bio-Techne Corporation
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs PTC Therapeutics, Inc.
Cost Insights: Breaking Down Dr. Reddy's Laboratories Limited and ACADIA Pharmaceuticals Inc.'s Expenses
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Dyne Therapeutics, Inc.